Minocycline Protects Pc12 Cells from Ischemic-Like Injury and Inhibits 5-Lipoxygenase Activation

Y Song,EQ Wei,WP Zhang,L Zhang,JR Liu,Z Chen
DOI: https://doi.org/10.1097/00001756-200410050-00007
2004-01-01
Neuroreport
Abstract:Minocycline protects animals against cerebral ischemia by inhibiting inflammation. To determine whether minocycline protects PC12 cells from in vitro ischemic-like injury and affects pro-inflammatory 5-lipoxygenase activation, the cell viability and 5-lipoxygenase translocation to nuclear membrane were observed after oxygen-glucose deprivation (OGD). We found that OGD reduced cell viability, which was attenuated by minocycline and 5-lipoxygenase inhibitor caffeic acid. 5 -Lipoxygenase protein was detected in PC12 cells by immunohistochemical and Western blot analyses. OGD induced 5-lipoxygenase translocation to nuclear membranes, which was abolished by minocycline and caffeic acid. Thus, minocycline can protect PC12 cells from in vitro ischemic-like injury, and this effect may be partly related to the inhibition of 5-lipoxygenase activation.
What problem does this paper attempt to address?